Cutaneous eruption due to indoramin.
Farrell
A M
AM
Bunker
C B
CB
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007217:Indoramin / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D007217:Indoramin